Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proactive versus reactive topical corticosteroid treatment for vulval lichen sclerosus
ISRCTN72275160Phase 4Active, not recruiting
- Sponsor
- Nottingham Clinical Trials Unit
- Start
- Apr 2024
01
Overview
Phase 4, randomised, open-label trial of corticosteroids in vulvar lichen sclerosus (LS) (2 arms), sponsored by Nottingham Clinical Trials Unit. Primary endpoint: Number of flares over 12 months. Started Apr 2024; status: active, not recruiting.
02
Drugs
corticosteroids
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on ISRCTN72275160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN72275160.